GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Bought in ISA 10.6p live price 9.30am , excepted the offer last night with funds*
Can see the benefit in this case of OO following placing privately beforehand at same price .
Also what little understanding posters on here seem to have of RI & OOs.
Most cases it goes in opposite direction and holders feel left out by small allocation .
Bought some more executed 9.30am at 10.5p, the idea since passing on the OO with ( D ).
41/2 times as many as the small offer 0.5p cheaper.
OO just two weeks ago.
Just had another nibble myself, 5k at bargain prices.
Climbing....I wish it was 😀
Ripley, back in, hopefully in time for the awaited rebound. You made some good calls on sclp in the past if I remember correctly.
Violindog I was never out , I just buy a few more at times , might sell those ones back at a higher price .
I have a lot off them .
Ripley....hopefully... we will all profit one day...currently I need the SP higher to break even @14 p
One month on can still buy for 10.5p
Showing 10% spread.
Improving a little over last two weeks now 12p spread 8.7%
Doesn’t seem too much stock around at the moment which bodes well if we have continued positive data and/or another licensing deal.
If so, lucky the'res not more stock around . If there was I'd hate to think where the SP would be. I always thought If stock was scarce the SP would rise. IMO.
Come on own up. Who bought the 52 (£6.50) shares to try and prove me wrong?. LOL.
It was not me. My new average is high enough, thank you.
It is good to see that the short sellers are nit attacking Scancell as they have done to other LSE shares. Could be too risky if a deal is announced. . .
Hardman & Co Healthcare Index.
â–º Despite setbacks over the past two years, since inauguration in 2009, the CAGR for the HHI has been 12.0%, compared with 3.3% for the FTSE All-Share Index and 0.5% for the FTSE AIM All-Share Index, highlighting the attractiveness of the healthcare sector as a long-term investment, despite being capital-intensive.
â–º Of the 52 companies included in the HHI, only 15 recorded an increase in their share prices in 2023, four benefiting from M&A activity. One marked time (change
► The variance between the best- and worst-performing stocks was in line with historic data, at 223% – hVIVO (HVO) rising 138% and Advanced Oncotherapy (AVO) down 86% at the time of being suspended; the median share price change was -20%.
â–º In relative terms, 17 stocks outperformed the index during 2023, with the other 35 under performing.
â–º After two really good years in 2020 and 2021, biotech and healthcare stocks had become overvalued, as evidenced by a marked reduction in M&A activity. Since then, along with global markets in general, biotech and healthcare stocks have been re-rated downwards. In addition, the trend towards greater risk aversion in response to geopolitical events, higher inflation and higher interest rates have made it more difficult to raise capital over the past two years.
My broker has this up 13% today at 3pm hit 12p at 3pm closed 11.2p
Here up 6.67% with 10% spread.
Hardman & Co Healthcare Index.
â–º Despite setbacks over the past two years, since inauguration in 2009, the CAGR for the HHI has been 12.0%, compared with 3.3% for the FTSE All-Share Index and 0.5% for the FTSE AIM All-Share Index, highlighting the attractiveness of the healthcare sector as a long-term investment, despite being capital-intensive.
â–º Of the 52 companies included in the HHI, only 15 recorded an increase in their share prices in 2023, four benefiting from M&A activity. One marked time , no change .
These posts are more annoying that a YouTube advert.
Than
I'd have to understand it before I could get annoyed.
SCLP is sitting at number 23 on the Leader board Up 9.52% but is showing it is only Up 6.67% now due to an uncrossing trade pushing it down. This should show a rise in the morning when it reverts to the true closing price. A good rise today and hopefully an RNS soon.
DeAar & RuckRover you could learn from ICB888.
Please put me on filter I have no interest in what you two have got to say.
From this site.
Shares in Issue 927.82m
Market Cap. £95.10m
Market Size 30,000
PE Ratio -6.836068
Earnings -1.4994
Dividend 0.00
Yield 0.00%
Chelsea11, ratcliffewriter , abusive probably not real.
violindog ?
Obvious why I chose to compare below.
AVCT, VAL, DEST, SCLP. & PREM, VAST, GCM, QED and BLVN .
AIM bb not strait.
The site itself as a little earlier prevents posts and deletes some ?
Back to the 10.25p calendar year resistance .
Was no rush to top up end of 2023 , cheaper many times this year.
Must be boring if this is were most of your share investments funds are.
Looks even cheaper today but the 3.9% decline has a 3.1% spread.